Table 1

Plasma ANP molecular forms in normal controls and patients with heart disease

StudyPlasma sample (n)DiagnosisPro-ANPANPPro-ANP/ANP
Thesis et al131Normal controlNoneMajor
Akiba et al1825Normal controlMinorMajor
Hunter et al1210, Pooled plasmaNormal controlEqualEqual
Ohashi et al391Normal controlNonePresent
Sato et al407, Pooled plasmaNormal controlMinorMajor
Meleagros et al191Normal controlMinorMajor0.24
Ando et al211Normal controlMinorMajor
Tan et al412Normal controlMinorMajor
Espiner et al421Normal controlMinorMajor
Azizi et al22Pooled plasmaNormal controlMinorMajor
Yamaji et al141Normal heart, pregnant womanMinorMajor
Predel et al434CRF, normotensionMinorMajor0.25
Ishizaka et al151HD, normal heartMinorMajor0.47
Cannella et al1610, pooledHD, normal heartMinorMajor
Akiba et al1810HD, normal heartMinorMajor
Hasegawa et al171HD, normal heartMinorMajor
Lindberg et al442HD, MV stenosis; HD, MIMinorMajor
Hunter et al127, Pooled plasmaHFEqualEqualPro-ANP=ANP
Yamaji et al143, Pooled plasmaHFMinorMajor
Meleagros et al191HFMinorMajor0.16
Mukoyama et al111HFMinorMajorPro-ANP<<ANP
Ando et al214NYHA class IMinorMajor0.087
11NYHA class IIMinorMajor0.45
5NYHA class IIIMajorMinor1.63
8NYHA class IVMajorMinor1.27
Azizi et al22Pooled plasmaHFMajorMinorPro-ANP>>ANP
  • ANP, atrial natriuretic peptide; CRF, chronic renal failure; HD, haemodialysis; HF, heart failure; Ir, immunoreactive; MI, myocardial infarction; MV, mitral valve; NYHA, New York Heart Association.